HSD17B13-IN-103

• UNSPSC Description:

  HSD17B13-IN-103 (Compound 44) is a HSD17B13 inhibitor. HSD17B13-IN-103 can be used in the study of non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)[1].

• Target Antigen:

  17β-HSD

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/hsd17b13-in-103.html

• Smiles:

  FC1=CC(C(NC[C@@H]2CC[C@H](CC2)N3C=C4C=CC(C5=CN(N=C5)C(F)F)=CC4=N3)=O)=CC(F)=C1O

• Molecular Weight:

  501.48

• References & Citations:

  [1]WO2024075051A1

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  3035000-89-3